HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[2012: news in neurology].

Abstract
In 2012, intramuscular midazolam appears as effective as intravenous lorezepam for the first line treatment of convulsive status epilepticus. Perampanel, a new anti-epileptic drug, will be soon available. Two oral treatments are now available for stroke prevention in atrial fibrillation setting. The methylphenidate and the Tai Chi could increase the walk capacity of patients suffering from Parkinson disease. A comprehensive cardiac work-up is essential for some congenital myopathy. A new drug against migraine seems free from vasoconstrictive effect. Antioxidants are harmful in Alzheimer disease. Some oral medication will be available for multiple sclerosis.
AuthorsV Alvarez, A O Rossetti, P Michel, T Kuntzer, B Nater, J-F Démonet, M Schluep, R Du Pasquier, F Vingerhoets
JournalRevue medicale suisse (Rev Med Suisse) Vol. 9 Issue 368 Pg. 62-5 (Jan 09 2013) ISSN: 1660-9379 [Print] Switzerland
Vernacular TitleNeurologie.
PMID23367707 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Anticonvulsants
Topics
  • Anticonvulsants (therapeutic use)
  • Cerebrovascular Disorders (therapy)
  • Dementia (therapy)
  • Dyskinesias (therapy)
  • Epilepsy (drug therapy)
  • Humans
  • Mental Disorders (therapy)
  • Neuroimmunomodulation (physiology)
  • Neurology (methods, trends)
  • Neuromuscular Diseases (therapy)
  • Therapies, Investigational (methods, trends)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: